NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to assess, in a controlled environment, the efficacy and safety of NRP104 and Adderall XR compared to placebo in treatment of children, aged 6-12, with ADHD.
Epistemonikos ID: 4a2481495dcd2c126a8fda74d110eab2da624c01
First added on: May 04, 2024